Skip to content

Secondary Prevention Education After Acute Myocardial Infarction

The Effect of Secondary Prevention Education Given to Individuals After Acute Myocardial Infarction on Physiological Parameters, Anxiety and Quality of Life

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04769219
Enrollment
86
Registered
2021-02-24
Start date
2020-03-01
Completion date
2021-08-31
Last updated
2024-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Education, Myocardial Infarction, Acute, Quality of Life

Keywords

myocardial infarction, anxiety, education, Quality of Life

Brief summary

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.

Detailed description

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.The population of the study will be the individuals hospitalized with the diagnosis of acute myocardial infarction in the Coronary Intensive Care Unit of Abant Izzet Baysal University Izzet Baysal Training and Research Hospital. The study will be conducted in a randomized controlled manner with two groups, 43 in the control group and 43 in the secondary prevention education group. CAG (Coronary Angiography) Procedure Training Form, Patient Identification Form, Physiological Parameters Form and Visual Analogue Scale, Spielberg State and Trait Anxiety Scale and Myocardial Infarction Dimensional Assessment Scale will be used to collect data. The data will be collected by face to face interview technique. For descriptive statistics, mean and standard deviation or median and minimum-maximum values for numerical variables, number and percentage values for categorical variables will be given. The Kolmogorov-Smirnov test (p \<0.05), skewness and kurtosis coefficients (should be ± 1) and X ̅ / SS \<4 inequalities will be examined at the same time, and the weight in which group will be preferred.

Interventions

OTHERSecondary prevention training

Secondary prevention training will be given after acute myocardial infarction

Sponsors

Abant Izzet Baysal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

the participant did not know which group he was in.

Intervention model description

There are 2 groups as intervention and control

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* First time AMI and inpatient treatment in the coronary intensive care unit, * Not having received training after AMI \* * Being 18 years or older, * Speak Turkish, * No problem in verbal communication, * Absence of hearing loss, * Not being diagnosed with a psychiatric illness, * Being conscious, * Being volunteer to participate in the study, * Routine check of cholesterol, HDL, LDL, triglyceride results at the beginning of the study and at 6 months.

Exclusion criteria

Not having had AMI for the first time * Having received training after AMI * Not willing to participate in the study, * Cannot speak Turkish, * Problems in verbal communication, * Having hearing loss, * Having a diagnosis of psychiatric illness, * Unconsciousness. * Cholesterol, HDL, LDL, triglyceride results were not routinely checked at the start and 6 months of the study.

Design outcomes

Primary

MeasureTime frameDescription
means of subjective anxiety scoressix monthsSpielberg State- Trait Anxiety Scale. The total score between 0-19 obtained from the state anxiety scale shows that there is no anxiety, the total score between 20-39 indicates mild, the average score between 40-59 indicates moderate, and the total score between 60-79 indicates severe anxiety, and over 60 points are needed for professional help. The scores obtained from the trait anxiety scale vary between 20 and 80. A high score means a high and a low level means anxiety
means of subjective quality of life scoressix monthsIt consists of 35 items and the quality of life is based on physical activity (12 items), insecurity (9 items), emotional response (4 items), addiction (3 items), diet (3 items), concerns about medication (2 items), Each sub-dimension of MIDAS, which measures seven domains as (2 items), is scored between 0-100. High scores indicate poor health.

Secondary

MeasureTime frameDescription
means of subjective pain scoresix monthsvisual analog scale. It consists of a straight line with endpoints that define end limits such as no pain and pain as bad as possible. The patient is asked to mark the level of pain on the line between the two endpoints.

Other

MeasureTime frameDescription
means of LDL cholesterol (mg/dl)six monthsThe values measured during routine blood checks will be taken for cholesterol values in this study.
means of blood pressure (mmHg)six monthsIn the study, a digital sphygmomanometer, which has been calibrated in comparison with the mercury sphygmomanometer, is used in order to prevent individual differences in the measurement of blood pressure. For accurate results, the sphygmomanometer sleeve is sized for adult individuals (width = about 20 cm, length = about 40 cm). In order for the blood pressure not to be affected by the conditions during the measurement, it is taken into account that the individual did not drink tea or coffee, take caffeine, and preferably did not eat during the 30 minutes prior to measurement.
means of triglyceride (mg/dl)six monthsThe values measured during routine blood checks will be taken for cholesterol values in this study.
means of total cholesterol (mg/dl)six monthsThe values measured during routine blood checks will be taken for cholesterol values in this study.
means of HDL cholesterol (mg/dl)six monthsThe values measured during routine blood checks will be taken for cholesterol values in this study.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026